With combined experience spanning over four decades, TE's engineering teams have expertise in minimally invasive technologies spanning across valvular, congenital and structural diseases. Having supported many of the industry's most ground breaking clinical studies, our design teams are partners of choice for innovation, providing content for 2 out of every 3 TAVR procedures worldwide.
Just a few short months after Dr. Alain Cribier's pioneering first TAVR procedure in 2002, TE Connectivity co-created a steerable large bore shaft for the delivery of a TAVR valve, evolving the face of structural heart medicine today.
Intrinsic with the growth and clinical success of minimally invasive heart therapies, TE provides content for 2 out of every 3 TAVR procedures worldwide. A premier partner for design and manufacturing, TE has expertise in aortic, mitral and tricuspid valve solutions.
Providing comprehensive solutions to enable LAA occlusion device delivery, PFO closure, protection device deployment and aortic valvuloplasty, TE has expertise not only in access, delivery and closure but additionally, is working towards the future in catheter based imaging including IVUS, ICE and OCT, tools essential in the diagnosis and treatment of structural heart patients.
- Septal crossing
- Access & Closure
- Percutaneous Valve Delivery Systems
- Valvuloplasty Balloon Dilation Catheters
- Guiding Sheaths
- Transeptal Access & Crossing Systems
- Transapical Access Systems
- Sizing Balloon Catheters
- Occlusion Catheters
- Cardioplegia Delivery Systems